Bond Kommunalbanken 0% ( XS0302825582 ) in USD

Issuer Kommunalbanken
Market price refresh price now   100 %  ▲ 
Country  Norway
ISIN code  XS0302825582 ( in USD )
Interest rate 0%
Maturity 04/06/2037



Prospectus brochure in PDF format

Minimal amount 10 000 USD
Total amount 182 330 000 USD
Detailed description Kommunalbanken is a Norwegian state-owned bank primarily providing financing to municipalities and county councils.

Kommunalbanken's USD-denominated bond (XS0302825582) is a 0% coupon, ?182,330,000 issue maturing on 04/06/2037, trading at 100% with a minimum lot size of ?10,000 and semi-annual coupon payments.








BASE PROSPECTUS








KOMMUNALBANKEN AS
Incorporated with limited liability in the Kingdom of Norway
Programme For The Issuance Of Debt Instruments
Application has been made to the Luxembourg Stock Exchange for debt instruments (the
"Instruments") issued by Kommunalbanken AS (the "Issuer") under the programme (the
"Programme") described in this document (as amended or supplemented, the "Base Prospectus")
to be admitted to listing on the official list and to trading on the regulated market of the
Luxembourg Stock Exchange during the period of twelve months after the date of this document.
The regulated market of the Luxembourg Stock Exchange is a regulated market for the purposes
of Directive 2014/65/EU on markets in financial instruments (as amended, "MiFID II"). The
Programme also permits Instruments to be issued on the basis that they will not be admitted to
listing, trading and/or quotation by any competent authority, stock exchange and/or quotation
system or to be admitted to listing, trading and/or quotation by such other or further competent
authorities, stock exchanges and/or quotation systems as may be agreed with the Issuer.
The Luxembourg Commission de Surveillance du Secteur Financier (the "CSSF"), in its capacity
as competent authority under Article 6(1) of the Luxembourg Act dated 16 July 2019 relating to
prospectuses for securities (the "Luxembourg Prospectus Law"), has approved this Base
Prospectus as a base prospectus for the purposes of Article 8 of the Regulation (EU) 2017/1129
(the "Prospectus Regulation"). By approving the Base Prospectus, the CSSF gives no
undertaking as to the economic and financial opportuneness of the transactions contemplated by
this Base Prospectus or the quality or solvency of the Issuer in line with the provisions of Article
6(4) of the Luxembourg Prospectus Law. The CSSF only approves this Base Prospectus as
meeting the standards of completeness, comprehensibility and consistency imposed by the
Prospectus Regulation. Such approval should not be considered as an endorsement of the Issuer
nor as an endorsement of the quality of any Instruments that are the subject of this Base
Prospectus. Investors should make their own assessment as to the suitability of investing in such
Instruments.
In compliance with Article 21(8) of the Prospectus Regulation, this Base Prospectus is valid for
a period of twelve months from its date of approval, with the validity period ending on 21 March
2025. The obligation to supplement this Base Prospectus in the event of significant new factors,
material mistakes or material inaccuracies does not apply when this Base Prospectus is no longer
valid.
Secondary offerings (uridashi) of Instruments may be made in Japan. This Base Prospectus does
not constitute an approved document under the Prospectus Regulation for the purposes of any
secondary offerings (uridashi) of Instruments made in Japan.
The Instruments have not been, and will not be, registered under the U.S. Securities Act of 1933,
as amended (the "Securities Act"), or with any securities regulatory authority of any state or other
jurisdiction of the United States, and may not be offered, sold or delivered within the United
States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S ("Regulation
10275511842-v18

70-41067948




S") under the Securities Act), except pursuant to an exemption from, or in a transaction not subject
to, the registration requirements of the Securities Act.
The Instruments are being offered and sold (i) outside the United States to non-U.S. persons in
reliance on Regulation S (the "Regulation S Instruments") and (ii) within the United States to
persons who are both "qualified institutional buyers" (each, a "QIB") within the meaning of Rule
144A ("Rule 144A") under the Securities Act and "qualified purchasers" (each, a "QP") within
the meaning of Section 2(a)(51)(A) of the U.S. Investment Company Act of 1940, as amended
(the "Investment Company Act"), and the rules and regulations thereunder, in each case acting
for their own account or for the account of one or more QIBs who are also QPs in reliance on
Rule 144A (the "Rule 144A Instruments"). Prospective purchasers are hereby notified that
sellers of the Instruments may be relying on the exemption from the provisions of Section 5 of
the Securities Act provided by Rule 144A. For a description of these and certain further
restrictions on offers, sales and transfers of Instruments and the distribution of this Base
Prospectus, see "Subscription and Sale" and "Transfer Restrictions".
In the case of any Instruments which are to be admitted to trading on a regulated market within
the European Economic Area (the "EEA") or offered to the public in a Member State of the EEA
in circumstances which require the publication of a prospectus under the Prospectus Regulation,
or which are offered to the public in the United Kingdom (the "UK") in circumstances which
require the publication of a prospectus under the Prospectus Regulation as it forms part of
domestic law of the UK by virtue of the European Union (Withdrawal) Act 2018 (the "EUWA"),
the minimum specified denomination shall be EUR100,000 (or equivalent in another currency as
at the date of the issue of the Instruments) and, in the case of Rule 144A Instruments and any
Instruments issued as part of a Tranche (as defined herein) of Instruments that contain both
Regulation S Instruments and Rule 144A Instruments, U.S.$100,000 (or equivalent in another
currency).
There are certain risks related to the issue of Instruments under the Programme which
investors should ensure they fully understand (see "Risk Factors").
Arranger for the Programme
MORGAN STANLEY
Dealers
BARCLAYS
BMO CAPITAL MARKETS
BOFA SECURITIES
BNP PARIBAS
CITIGROUP
CRÉDIT AGRICOLE CIB
DAIWA CAPITAL MARKETS EUROPE
DEUTSCHE BANK
GOLDMAN SACHS BANK EUROPE SE
HSBC
J.P. MORGAN
KOMMUNALBANKEN AS
MIZUHO
MORGAN STANLEY
NOMURA
RBC CAPITAL MARKETS
SEB
TD SECURITIES
UBS INVESTMENT BANK


21 March 2024
10275511842-v18

70-41067948




IMPORTANT NOTICES
This Base Prospectus may only be used for the purpose for which it has been published.
The Issuer (in relation to itself and the Instruments only) accepts responsibility for the information
contained in this Base Prospectus and any relevant Final Terms (as defined herein). The Issuer declares
that, to the best of its knowledge, the information contained in this Base Prospectus is in accordance with
the facts and the Base Prospectus makes no omission likely to affect its import.
Each Tranche of Instruments will be issued on the terms set out herein under "Terms and Conditions of the
Instruments" (the "Conditions"), as completed by a document specific to such Tranche called final terms
(the "Final Terms") or as amended and/or replaced in a separate prospectus specific to such Tranche (the
"Drawdown Prospectus"), as described under "Final Terms and Drawdown Prospectuses" below. In the
case of a Tranche of Instruments which is the subject of a Drawdown Prospectus, each reference in this
Base Prospectus to (1) information being specified or identified in the relevant Final Terms shall be read
and construed as a reference to such information being specified or identified in the relevant Drawdown
Prospectus and (2) terms being completed by the relevant Final Terms shall be read and construed as a
reference to such terms being supplemented, amended and/or replaced by the relevant Drawdown
Prospectus, unless the context requires otherwise.
This document should be read and construed together with any supplement hereto and any other information
deemed to be incorporated by reference herein and, in relation to any Tranche of Instruments which is the
subject of Final Terms, should be read and construed together with the relevant Final Terms.
The Issuer has confirmed to the dealers (the "Dealers") named under "Subscription and Sale" below that
this Base Prospectus contains all information which is material in the context of the Instruments; that the
Base Prospectus is true, accurate and complete in all material respects and is not misleading; that the
opinions and intentions expressed therein are honestly held and based on reasonable assumptions; that there
are no other facts in relation to the information contained or incorporated by reference in this Base
Prospectus or in relation to such opinions or intentions the omission of which would, in the context of the
Programme or the issue of the Instruments, make any statement in this Base Prospectus or the opinions or
intentions expressed therein misleading in any material respect; and that all reasonable enquiries have been
made to verify the foregoing. The Issuer has further confirmed to the Dealers that this Base Prospectus
contains all such information as may be required by all applicable laws, rules and regulations.
No person has been authorised by the Issuer to give any information or to make any representation not
contained in or not consistent with this Base Prospectus or any documents incorporated by reference herein
or other document entered into in relation to the Programme or any information supplied by the Issuer or
such other information as is in the public domain and, if given or made, such information or representation
should not be relied upon as having been authorised by the Issuer or any Dealer.
No representation or warranty is made or implied by the Dealers or any of their respective affiliates, and
neither the Dealers nor any of their respective affiliates makes any representation or warranty or accepts
any responsibility, as to the accuracy or completeness of the information contained in this Base Prospectus.
Neither this Base Prospectus nor any Final Terms constitutes an offer or an invitation to subscribe for or
purchase any Instruments and should not be considered as a recommendation by the Issuer, the Dealers or
any of them that any recipient of this Base Prospectus or any Final Terms should subscribe for or purchase
any Instruments. Each recipient of this Base Prospectus or any Final Terms shall be taken to have made its
own investigation and appraisal of the condition (financial or otherwise) of the Issuer.
Neither the delivery of this Base Prospectus or any Final Terms nor the offering, sale or delivery of any
Instrument shall, in any circumstances, create any implication that the information contained in this Base
Prospectus is true subsequent to the date thereof or the date upon which this Base Prospectus has been most
recently amended or supplemented or that there has been no adverse change in the financial or trading
position of the Issuer since the date thereof or, if later, the date upon which this Base Prospectus has been
most recently amended or supplemented or that any other information supplied in connection with the
Programme is correct at any time subsequent to the date on which it is supplied or, if different, the date
indicated in the document containing the same.
The distribution of this Base Prospectus and any Final Terms and the offering, sale and delivery of the
10275511842-v18
- i -
70-41067948




Instruments in certain jurisdictions may be restricted by law. Persons into whose possession this Base
Prospectus or any Final Terms comes are required by the Issuer and the Dealers to inform themselves about
and to observe any such restrictions. For a description of certain restrictions on offers, sales and deliveries
of Instruments and on the distribution of this Base Prospectus or any Final Terms and other offering material
relating to the Instruments, see "Subscription and Sale" and "Transfer Restrictions".
In particular, the Instruments have not been and will not be registered under the Securities Act or with any
securities regulatory authority of any state or other jurisdiction of the United States and may include
Instruments in bearer form, which are subject to U.S. tax law requirements. Instruments may not be offered,
sold or delivered within the United States or to, or for the account or benefit of, U.S. persons, except in
transactions exempt from the registration requirements of the Securities Act.
THE INSTRUMENTS HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE U.S.
SECURITIES AND EXCHANGE COMMISSION, ANY STATE SECURITIES COMMISSION IN
THE UNITED STATES OR ANY OTHER U.S. REGULATORY AUTHORITY, AND NONE OF
THE FOREGOING AUTHORITIES HAVE PASSED UPON OR ENDORSED THE MERITS OF
THE OFFERING OF INSTRUMENTS OR THE ACCURACY OR THE ADEQUACY OF THIS
BASE PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENCE IN THE UNITED STATES.
The Instruments are being offered and sold outside the United States only to persons that are non-U.S.
persons in reliance on Regulation S and within the United States only to QIBs that are also QPs in reliance
on Rule 144A. Prospective purchasers are hereby notified that sellers of the Instruments may be relying on
the exemption from the provision of Section 5 of the Securities Act provided by Rule 144A. For a
description of these and certain further restrictions on offers, sales, and transfers of Instruments and
distribution of this Base Prospectus, see "Subscription and Sale" and "Transfer Restrictions".
The Issuer will seek to qualify for an exemption from the definition of "investment company" under the
U.S. Investment Company Act of 1940, and will not register as an investment company in the United States
under the Investment Company Act. The Investment Company Act provides certain protections to investors
and imposes certain restrictions on registered investment companies, none of which will be applicable to
the Issuer or its investors.
Redemption of some Instruments may be made by delivery or transfer of securities or instrument(s) in a
company or fund (for example, shares of a company or fund shares of an exchange traded fund). The shares
of underlying entities which may be delivered or transferred (as the case may be) upon redemption of
Physical Delivery Instruments (as defined in the Conditions) are not shares in the Issuer.
As a result of the implementation of the BRRD (as defined herein) into Norwegian law, Holders of the
Instruments may be subject to write-down or conversion into equity on any application of the general bail-
in tool, which may result in such holders losing some or all of their investment. See "Risk Factors ­ Risks
Relating to the Issuer ­ Implementation of the Bank Recovery and Resolution Directive in Norway", "Risk
Factors ­ Risks Relating to the Instruments ­ Under the terms of the Instruments, investors will agree to be
bound by and consent to the exercise of any Norwegian bail-in power by the Norwegian resolution
authority" and Condition 20 in the Conditions.
Except for Conditions 3.2 and 20 (which are governed by the laws of the Kingdom of Norway), the
Instruments, all related contractual documentation (except for the VPS Agreement and the VPS Trustee
Agreement, which are governed by Norwegian law) and any non-contractual obligations arising out of or
in connection with them (except as aforesaid) are governed by English law. No assurance can be given as
to the impact of any possible judicial decision or change to the laws of the Kingdom of Norway or England
or administrative practice after the date of this Base Prospectus.
As at the date of this Base Prospectus, the Issuer is a limited liability company owned entirely by the
Norwegian State represented by the Ministry of Local Government and Regional Development and is
subject to the act of 13 June 1997 No 44 on Limited Liability Companies, as amended (the "Limited
Liability Companies Act"). The Norwegian State does not guarantee any of the Issuer's obligations,
including the Instruments and payment to Holders of Instruments, and is therefore solely dependent on the
creditworthiness of the Issuer. (See "Risk Factors ­ Factors which may affect the Issuer's ability to fulfil its
obligations under Instruments issued under the Programme ­ Risks relating to ownership by the Norwegian
State").
10275511842-v18
- ii -
70-41067948




The Issuer confirms that any information from third party sources has been accurately reproduced and that,
so far as it is aware and is able to ascertain from information published by such third party source, no facts
have been omitted which would render the reproduced information inaccurate or misleading.
IMPORTANT ­ EEA RETAIL INVESTORS
If the relevant Final Terms in respect of any Instruments includes a legend entitled "Prohibition of Sales to
EEA Retail Investors", the Instruments are not intended to be offered, sold or otherwise made available to
and should not be offered, sold or otherwise made available to any retail investor in the EEA. For these
purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11)
of Article 4(1) of MiFID II; or (ii) a customer within the meaning of Directive (EU) 2016/97 (the "EU
Insurance Distribution Directive"), where that customer would not qualify as a professional client as
defined in point (10) of Article 4(1) of MiFID II. Consequently no key information document required by
Regulation (EU) No 1286/2014 (as amended, the "EU PRIIPs Regulation") for offering or selling the
Instruments or otherwise making them available to retail investors in the EEA has been prepared and
therefore offering or selling the Instruments or otherwise making them available to any retail investor in
the EEA may be unlawful under the EU PRIIPs Regulation.
IMPORTANT ­ UK RETAIL INVESTORS
If the relevant Final Terms in respect of any Instruments includes a legend entitled "Prohibition of Sales to
UK Retail Investors", the Instruments are not intended to be offered, sold or otherwise made available to
and should not be offered, sold or otherwise made available to any retail investor in the UK. For these
purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8)
of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law of the UK by virtue of the
EUWA; or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act
2000, as amended (the "FSMA") and any rules or regulations made under the FSMA to implement the EU
Insurance Distribution Directive, where that customer would not qualify as a professional client, as defined
in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law of the UK by
virtue of the EUWA. Consequently no key information document required by the EU PRIIPs Regulation
as it forms part of domestic law of the UK by virtue of the EUWA (the "UK PRIIPs Regulation") for
offering or selling the Instruments or otherwise making them available to retail investors in the UK has
been prepared and therefore offering or selling the Instruments or otherwise making them available to any
retail investor in the UK may be unlawful under the UK PRIIPs Regulation.
MiFID II PRODUCT GOVERNANCE / TARGET MARKET
The relevant Final Terms in respect of any Instruments may include a legend entitled "MiFID II Product
Governance" which will outline the target market assessment in respect of the Instruments and which
channels for distribution of the Instruments are appropriate. Any person subsequently offering, selling or
recommending the Instruments (a "distributor") should take into consideration the target market
assessment; however, a distributor subject to MiFID II is responsible for undertaking its own target market
assessment in respect of the Instruments (by either adopting or refining the target market assessment) and
determining appropriate distribution channels.
A determination will be made in relation to each issue about whether, for the purpose of the MiFID Product
Governance rules under EU Delegated Directive 2017/593 (the "MiFID Product Governance Rules"),
any Dealer subscribing for any Instruments is a manufacturer in respect of such Instruments, but otherwise
neither the Arranger nor the Dealers nor any of their respective affiliates will be a manufacturer for the
purpose of the MiFID Product Governance Rules.
UK MiFIR PRODUCT GOVERNANCE / TARGET MARKET
The relevant Final Terms in respect of any Instruments may include a legend entitled "UK MiFIR Product
Governance" which will outline the target market assessment in respect of the Instruments and which
channels for distribution of the Instruments are appropriate. Any distributor should take into consideration
the target market assessment; however, a distributor subject to the Handbook Product Intervention and
Product Governance Sourcebook (the "UK MiFIR Product Governance Rules") of the UK Financial
Conduct Authority (the "FCA") is responsible for undertaking its own target market assessment in respect
of the Instruments (by either adopting or refining the target market assessment) and determining appropriate
distribution channels.
10275511842-v18
- iii -
70-41067948




A determination will be made in relation to each issue about whether, for the purpose of the UK MiFIR
Product Governance Rules, any Dealer subscribing for any Instruments is a manufacturer in respect of such
Instruments, but otherwise neither the Arranger nor the Dealers nor any of their respective affiliates will be
a manufacturer for the purpose of the UK MiFIR Product Governance Rules.
INDEX-LINKED INSTRUMENTS
By purchasing an Index Linked Instrument (as defined herein) referencing an index with one or more
underlying U.S. securities, an investor will be deemed to represent that it has not taken, and will not take,
any short position with respect to any of the underlying components of the relevant index that would cause
it to cease to be a Qualified Index (as defined herein) with respect to such investor, see "Risk Factors ­
Risks Relating to the Instruments ­ U.S. withholding tax may apply to Instruments with payments linked to
dividends paid by U.S. issuers".
No Index Linked Instruments will be issued referencing an index composed by the Issuer.
INSTRUMENTS ISSUED AS GREEN BONDS
None of the Dealers or any of their respective affiliates accepts any responsibility for any social,
environmental and/or sustainability assessment of any Instruments issued under the Programme as green
bonds (each, a "Green Bond") or makes any representation or warranty or assurance whether such
Instruments will meet any investor expectations or requirements regarding such "green", "sustainable",
"social" or similar labels (including in relation to Regulation (EU) 2020/852 on the establishment of a
framework to facilitate sustainable investment (the "EU Taxonomy Regulation") and any related technical
screening criteria, Regulation (EU) 2023/2631 on European Green Bonds and optional disclosures for
bonds marketed as environmentally sustainable and for sustainability-linked bonds (the "EU Green Bond
Regulation"), Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services
sector ("SFDR") and any implementing legislation and guidelines, or any similar legislation in the United
Kingdom) or any requirements of such labels as they may evolve from time to time.
None of the Dealers or any of their respective affiliates is responsible for the use or allocation of proceeds
for any Instruments issued as Green Bonds, nor the impact or monitoring of such use of proceeds nor do
any of the Dealers undertake to ensure that there are at any time sufficient Green Projects (as defined in the
section "Risk Factors" below) to allow for allocation of an amount equal to the net proceeds of the issue of
such Green Bonds in full. In addition, none of the Dealers is responsible for the assessment of the Issuer's
Green Bond Framework (as defined in the section "Use of Proceeds" below) including the assessment of
the applicable eligibility criteria in relation to Green Bonds set out in therein.
Additionally, the Arranger and the Dealers are not responsible for the assessment of the Green Bond
Framework, the Criteria Document (as defined in the section "Use of Proceeds" below) or the Second
Opinion (as defined in the section "Use of Proceeds" below), nor do they accept any responsibility as to the
accuracy and completeness of the information contained in the Green Bond Framework, the Criteria
Document, the Second Opinion or any Green Bond Report (as defined in the section "Use of Proceeds"
below), opinion, certification, assessment, Environmental, Social, and Governance ("ESG") rating or other
report in connection with the Green Bond Framework or any Instruments issued as Green Bonds.
No representation or assurance is given by the Dealers or any of their respective affiliates as to the suitability
or reliability of any opinion, certification or ESG rating of any third party made available in connection
with an issue of Instruments issued as Green Bonds (whether or not solicited by the Issuer), nor is any such
opinion, certification or ESG rating a recommendation by any Dealer or any of its affiliates to buy, sell or
hold any such Instruments and is current only as of the date it is issued. The criteria and/or considerations
that formed the basis of the Second Opinion or any such other opinion or certification may change at any
time and the Second Opinion may be amended, updated, supplemented, replaced and/or withdrawn.
Prospective investors must determine for themselves the relevance of any such opinion or certification
and/or the information contained therein. The Issuer's Green Bond Framework may also be subject to
review and change and may be amended, updated, supplemented, replaced and/or withdrawn from time to
time and any subsequent version(s) may differ from any description given in this Base Prospectus. The
Second Opinion provides an opinion on certain environmental and related considerations and is not
intended to address any credit, market or other aspects of an investment in any Instruments, including
without limitation market price, marketability, investor preference or suitability of any security. The Second
Opinion is a statement of opinion, not a statement of fact. In the event any such Instruments are, or are
10275511842-v18
- iv -
70-41067948




intended to be, listed, or admitted to trading on a dedicated "green", "sustainable" or other equivalently
labelled segment of a stock exchange or securities market, no representation or assurance is given by the
Dealers or any of their respective affiliates that such listing or admission will be obtained or maintained for
the lifetime of the Instruments. None of the Green Bond Framework, the Criteria Document, the Second
Opinion, the Green Bond Reports, any other certification, report or opinion relating to the Green Bond
Framework and/or Instruments issued as Green Bonds, any document referred to in any of the foregoing,
or the contents of any website referred to herein or therein are, or are deemed to be, incorporated in, or form
part of, this Base Prospectus and/or any Final Terms relating to Instruments issued as Green Bonds.
The Issuer and its Instruments may be the subject of unsolicited ESG ratings. Any such ESG ratings are not
necessarily indicative of the Issuer's current or future operating or financial performance, or any future
ability to service any Instruments. Furthermore, ESG ratings shall not be deemed to be a recommendation
by the Issuer, the Dealers or any other person to buy, sell or hold Instruments. ESG ratings may vary
amongst ESG ratings agencies as the methodologies used to determine ESG ratings may differ. Currently,
the providers of such ESG ratings are not subject to any regulatory or other similar oversight in respect of
their determination and award of ESG ratings.
Defined terms used in this subsection have the meanings given to them elsewhere in this Base Prospectus.
PRODUCT CLASSIFICATION PURSUANT TO SECTION 309B OF THE
SECURITIES AND FUTURES ACT 2001 OF SINGAPORE
The Final Terms in respect of any Instruments may include a legend entitled "Singapore Securities and
Futures Act Product Classification" which will state the product classification of the Instruments pursuant
to Section 309B(1) of the Securities and Futures Act 2001 of Singapore (as modified or amended from time
to time, the "SFA"). The Issuer will make a determination in relation to each relevant issue about the
classification of Instruments being offered for the purposes of Section 309B(1)(a). Any such legend
included on the relevant Final Terms will constitute notice to the "relevant persons" for the purposes of
Section 309B(1)(c) of the SFA.
EU BENCHMARKS REGULATION
Interest and/or other amounts payable under the Instruments may be calculated by reference to certain
indices and reference rates, including BBSW, BKBM, STR, EONIA, EURIBOR, NIBOR, SOFR, SONIA,
STIBOR and the U.S. Federal Funds Rate (each as defined herein). Any such reference rate or index may
constitute a benchmark for the purposes of Regulation (EU) 2016/1011 (the "EU Benchmarks
Regulation").
As at the date of this Base Prospectus, the European Money Markets Institute, the administrator of EONIA
and EURIBOR, ASX Benchmarks Limited, the administrator of BBSW, Norske Finansielle Referanser AS,
the administrator of NIBOR, and Swedish Financial Benchmark Facility AB, the administrator of STIBOR,
are included in the register of administrators and benchmarks established and maintained by the European
Securities and Markets Authority ("ESMA") under the EU Benchmarks Regulation.
As at the date of this Base Prospectus, none of the New Zealand Financial Markets Association, the
administrator of BKBM, the European Central Bank, the administrator of STR, the Federal Reserve Bank
of New York, the administrator of SOFR and the U.S. Federal Funds Rate, or the Bank of England, the
administrator of SONIA, are included in ESMA's register of administrators and benchmarks under the EU
Benchmarks Regulation.
Not every reference rate will fall within the scope of the EU Benchmarks Regulation and transitional
provisions in the EU Benchmarks Regulation may result in the administrator of a particular benchmark not
appearing in the ESMA register at the date of the Final Terms. The registration status of any administrator
under the EU Benchmarks Regulation is a matter of public record and, save where required by applicable
law, the Issuer does not intend to update the Final Terms to reflect any change in the registration status of
the administrator.
DEFINITIONS
In this Base Prospectus, unless otherwise specified, references to the "EEA" are references to the European
Economic Area, references to a "Member State" are references to a Member State of the EEA, references
to the "UK" are references to the United Kingdom, the expression "Prospectus Regulation" means
10275511842-v18
- v -
70-41067948




Regulation (EU) 2017/1129, references to "EUR", "" or "euro" are to the currency introduced at the start
of the third stage of European economic and monetary union, and as defined in Article 2 of Council
Regulation (EC) No 974/98 of 3 May 1998 on the introduction of the euro, as amended, references to the
"US", the "U.S." and the "United States" are to the United States of America, references to "U.S.$", "USD"
and "U.S. dollars" are to the lawful currency of the United States, references to "£", "Sterling" and "Pound
Sterling" are to the lawful currency of the UK, references to "JPY" and "Japanese Yen" are to the lawful
currency of Japan, references to "NOK" and "Norwegian krone" are to the lawful currency of the Kingdom
of Norway, references to "Renminbi" and "CNY" are to the lawful currency of the People's Republic of
China (excluding the Hong Kong Special Administrative Region of the PRC, the Macau Special
Administrative Region of the PRC and Taiwan) (the "PRC"), references to "S$" are to the lawful currency
of Singapore, references to "Moody's" are to Moody's France SAS and references to "S&P" are references
to S&P Global Ratings Europe Limited.
Any reference in this Base Prospectus to any legislation (whether primary legislation or regulations or other
subsidiary legislation made pursuant to primary legislation) shall be construed as a reference to such
legislation as the same may have been, or may from time to time be, amended, superseded or re-enacted.
ENFORCEMENT OF FOREIGN JUDGMENTS
The Issuer is a government funding agency incorporated under the laws of the Kingdom of Norway. All of
the officers and directors named herein reside outside of the United States and all or a substantial portion
of the assets of the Issuer and its officers and directors are located outside the United States. As a result,
prospective investors may have difficulties effecting service of process in the United States upon the Issuer
or such persons in connection with any lawsuits related to the Instruments, including actions arising under
the federal securities laws of the United States. In addition, investors may have difficulties in enforcing in
original actions brought in courts in jurisdictions outside the United States, liabilities predicated upon U.S.
securities laws.
AVAILABLE INFORMATION
The Issuer has agreed that, for so long as any Instruments are "restricted securities" as defined in
Rule 144(a)(3) under the Securities Act, it will during any period that it is neither subject to Section 13 or
15(d) of the U.S. Securities and Exchange Act of 1934, as amended (the "Exchange Act"), nor exempt
from reporting pursuant to Rule 12g3-2(b) thereunder furnish, upon request, to any Holder or beneficial
owner of Instruments or any prospective purchaser designated by any such Holder (as defined herein) or
beneficial owner, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities
Act.
STABILISATION
IN CONNECTION WITH THE ISSUE OF ANY TRANCHE OF INSTRUMENTS, THE DEALER OR
DEALERS (IF ANY) NAMED AS THE STABILISATION MANAGER(S) IN THE RELEVANT FINAL
TERMS (THE "STABILISATION MANAGER(S)") (OR PERSONS ACTING ON BEHALF OF ANY
STABILISATION MANAGER(S)) MAY OVERALLOT INSTRUMENTS OR EFFECT
TRANSACTIONS WITH A VIEW TO SUPPORTING THE MARKET PRICE OF THE INSTRUMENTS
AT A LEVEL HIGHER THAN THAT WHICH MIGHT OTHERWISE PREVAIL.
HOWEVER, STABILISATION MAY NOT NECESSARILY OCCUR. ANY STABILISATION
ACTION MAY BEGIN ON OR AFTER THE DATE ON WHICH ADEQUATE PUBLIC DISCLOSURE
OF THE FINAL TERMS OF THE OFFER OF THE RELEVANT TRANCHE OF INSTRUMENTS IS
MADE AND, IF BEGUN, MAY CEASE AT ANY TIME, BUT IT MUST END NO LATER THAN THE
EARLIER OF 30 DAYS AFTER THE ISSUE DATE OF THE RELEVANT TRANCHE OF
INSTRUMENTS AND 60 DAYS AFTER THE DATE OF THE ALLOTMENT OF THE RELEVANT
TRANCHE OF INSTRUMENTS. ANY STABILISATION ACTION OR OVER-ALLOTMENT MUST
BE CONDUCTED BY THE STABILISATION MANAGER(S) (OR PERSONS ACTING ON BEHALF
OF THE STABILISATION MANAGER(S)) IN ACCORDANCE WITH ALL APPLICABLE LAWS
AND RULES.
10275511842-v18
- vi -
70-41067948




FORWARD-LOOKING STATEMENTS
This Base Prospectus includes "forward-looking statements". All statements other than statements of
historical fact included in this Base Prospectus, including, without limitation, those regarding the Issuer's
financial position, business strategy, plans and objectives of management for future operations, are forward-
looking statements. These forward-looking statements are identified by their use of terms and phrases such
as "anticipate", "believe", "could", "estimate", "expect", "intend", "may", "plan", "predict", "project", "will"
and similar terms and phrases, including references to assumptions.
Such forward-looking statements are not guarantees of future performance and involve known and
unknown risks, uncertainties and other factors which may cause the actual results, performance or
achievements, or industry results.
If one or more of the risks or uncertainties described under "Risk Factors" or elsewhere in this Base
Prospectus materialise, or if underlying assumptions prove incorrect, the Issuer's actual results, performance
or achievements or industry results may be materially different from any future results, performance or
achievements expressed or implied by such forward-looking statements. Such forward-looking statements
are based on numerous assumptions regarding the Issuer's present and future business strategies and the
environment in which the Issuer will operate in the future. These forward-looking statements speak only as
of the date of this Base Prospectus or as of such earlier date at which such statements are expressed to be
given. The Issuer expressly disclaims any obligation or undertaking to release publicly any updates or
revisions to any forward-looking statement contained herein to reflect any change in the Issuer's
expectations with regard thereto or any change in events, conditions or circumstances on which any such
statement is based.
10275511842-v18
- vii -
70-41067948




CONTENTS

Page
IMPORTANT NOTICES .............................................................................................................................. i
OVERVIEW ................................................................................................................................................. 1
RISK FACTORS .......................................................................................................................................... 9
INFORMATION INCORPORATED BY REFERENCE .......................................................................... 37
FINAL TERMS AND DRAWDOWN PROSPECTUSES ........................................................................ 41
RATINGS ................................................................................................................................................... 42
TERMS AND CONDITIONS OF THE INSTRUMENTS ........................................................................ 44
PROVISIONS RELATING TO THE INSTRUMENTS WHILST IN GLOBAL FORM ....................... 188
FORM OF FINAL TERMS ...................................................................................................................... 195
USE OF PROCEEDS ............................................................................................................................... 239
KOMMUNALBANKEN AS ................................................................................................................... 242
TAXATION ............................................................................................................................................. 248
CERTAIN ERISA AND RELATED CONSIDERATIONS .................................................................... 250
SUBSCRIPTION AND SALE ................................................................................................................. 253
TRANSFER RESTRICTIONS ................................................................................................................ 261
CLEARING AND SETTLEMENT.......................................................................................................... 267
GENERAL INFORMATION .................................................................................................................. 271

10275511842-v18
- viii -
70-41067948



Document Outline